Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases

Author： Giacoppo Sabrina   Mandolino Giuseppe   Galuppo Maria   Bramanti Placido   Mazzon Emanuela  

Publisher： MDPI

E-ISSN： 1420-3049|19|11|18781-18816

ISSN： 1420-3049

Source： Molecules, Vol.19, Iss.11, 2014-11, pp. : 18781-18816

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Neurobiology and Promising New Treatment in Depression

By Jeon Sang Won   Kim Yong-Ku  

International Journal of Molecular Sciences, Vol. 17, Iss. 3, 2016-03 ,pp. : 381-381

MDPI

Access to resources Recommend Favorite

Xanthenedione Derivatives, New Promising Antioxidant and Acetylcholinesterase Inhibitor Agents

By Seca Ana M. L.   Leal Stephanie B.   Pinto Diana C. G. A.   Barreto Maria Carmo   Silva Artur M. S.  

Molecules, Vol. 19, Iss. 6, 2014-06 ,pp. : 8317-8333

MDPI

Access to resources Recommend Favorite

New Aspects of Gene-Silencing for the Treatment of Cardiovascular Diseases

By Koenig Olivia   Walker Tobias   Perle Nadja   Zech Almuth   Neumann Bernd   Schlensak Christian   Wendel Hans-Peter   Nolte Andrea  

Pharmaceuticals, Vol. 6, Iss. 7, 2013-07 ,pp. : 881-914

MDPI

Access to resources Recommend Favorite

Coenzyme Q10 and Neurological Diseases

By Mancuso Michelangelo   Orsucci Daniele   Calsolaro Valeria   Choub Anna   Siciliano Gabriele  

Pharmaceuticals, Vol. 2, Iss. 3, 2009-12 ,pp. : 134-149

MDPI

Access to resources Recommend Favorite

Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases

By Robak Tadeusz   Korycka Anna   Lech-Maranda Ewa   Robak Pawel  

Molecules, Vol. 14, Iss. 3, 2009-03 ,pp. : 1183-1226

MDPI

Access to resources Recommend Favorite